A View from the past into our collective future: the oncofertility consortium vision statement.

Journal Article (Journal Article)

PURPOSE: Today, male and female adult and pediatric cancer patients, individuals transitioning between gender identities, and other individuals facing health extending but fertility limiting treatments can look forward to a fertile future. This is, in part, due to the work of members associated with the Oncofertility Consortium. METHODS: The Oncofertility Consortium is an international, interdisciplinary initiative originally designed to explore the urgent unmet need associated with the reproductive future of cancer survivors. As the strategies for fertility management were invented, developed or applied, the individuals for who the program offered hope, similarly expanded. As a community of practice, Consortium participants share information in an open and rapid manner to addresses the complex health care and quality-of-life issues of cancer, transgender and other patients. To ensure that the organization remains contemporary to the needs of the community, the field designed a fully inclusive mechanism for strategic planning and here present the findings of this process. RESULTS: This interprofessional network of medical specialists, scientists, and scholars in the law, medical ethics, religious studies and other disciplines associated with human interventions, explore the relationships between health, disease, survivorship, treatment, gender and reproductive longevity. CONCLUSION: The goals are to continually integrate the best science in the service of the needs of patients and build a community of care that is ready for the challenges of the field in the future.

Full Text

Duke Authors

Cited Authors

  • Woodruff, TK; Ataman-Millhouse, L; Acharya, KS; Almeida-Santos, T; Anazodo, A; Anderson, RA; Appiah, L; Bader, J; Becktell, K; Brannigan, RE; Breech, L; Bourlon, MT; Bumbuliene, Ž; Burns, K; Campo-Engelstein, L; Campos, JR; Centola, GM; Chehin, MB; Chen, D; De Vos, M; Duncan, FE; El-Damen, A; Fair, D; Famuyiwa, Y; Fechner, PY; Fontoura, P; Frias, O; Gerkowicz, SA; Ginsberg, J; Gracia, CR; Goldman, K; Gomez-Lobo, V; Hazelrigg, B; Hsieh, MH; Hoyos, LR; Hoyos-Martinez, A; Jach, R; Jassem, J; Javed, M; Jayasinghe, Y; Jeelani, R; Jeruss, JS; Kaul-Mahajan, N; Keim-Malpass, J; Ketterl, TG; Khrouf, M; Kimelman, D; Kusuhara, A; Kutteh, WH; Laronda, MM; Lee, JR; Lehmann, V; Letourneau, JM; McGinnis, LK; McMahon, E; Meacham, LR; Mijangos, MFV; Moravek, M; Nahata, L; Ogweno, GM; Orwig, KE; Pavone, ME; Peccatori, FA; Pesce, RI; Pulaski, H; Quinn, G; Quintana, R; Quintana, T; de Carvalho, BR; Ramsey-Goldman, R; Reinecke, J; Reis, FM; Rios, J; Rhoton-Vlasak, AS; Rodriguez-Wallberg, KA; Roeca, C; Rotz, SJ; Rowell, E; Salama, M; Saraf, AJ; Scarella, A; Schafer-Kalkhoff, T; Schmidt, D; Senapati, S; Shah, D; Shikanov, A; Shnorhavorian, M; Skiles, JL; Smith, JF; Smith, K; Sobral, F; Stimpert, K; Su, HI; Sugimoto, K; Suzuki, N; Thakur, M; Victorson, D; Viale, L; Vitek, W; Wallace, WH; Wartella, EA; Westphal, LM; Whiteside, S; Wilcox, LH; Wyns, C; Xiao, S; Xu, J; Zelinski, M

Published Date

  • January 2021

Published In

Volume / Issue

  • 38 / 1

Start / End Page

  • 3 - 15

PubMed ID

  • 33405006

Pubmed Central ID

  • PMC7786868

Electronic International Standard Serial Number (EISSN)

  • 1573-7330

Digital Object Identifier (DOI)

  • 10.1007/s10815-020-01983-4


  • eng

Conference Location

  • Netherlands